Dana N. Loury - Concepedia

Author

Dana N. Loury

University of California, Davis

Also Known As

D N Loury, D.N LOURY, D.N. Loury, DANA N LOURY, Dana N. Loury

Publications

708

Citations

H-Index

Concepts

All Affiliations

University of California, Davis Institute of Organic Chemistry FX Palo Alto Laboratory University of Hertfordshire

About

Dana N. Loury is an author at University of California, Davis specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	492
2	Biochemistry	10	10	373
3	Social Sciences	3	3	228
4	Natural Sciences	2	2	48
5	Health Sciences	1	1	46

Dana N. Loury

Publications

686

Citations

H-Index

Page 1

	Year	Citations
Identification of a single α<sub>1</sub>‐adrenoceptor corresponding to the α<sub>1A</sub>‐subtype in rat submaxillary gland Anton D. Michel, Dana N. Loury, R.L. Whiting British Journal of Pharmacology Displacement IsothermsRat Submaxillary GlandPharmacotherapyExperimental PharmacologySocial Sciences	1989	112
Differences between the α<sub>2</sub>‐adrenoceptor in rat submaxillary gland and the α<sub>2A</sub>‐ and α<sub>2B</sub>‐adrenoceptor subtypes Anton D. Michel, Dana N. Loury, R.L. Whiting British Journal of Pharmacology Rat Submaxillary GlandExperimental PharmacologySocial SciencesInflammationMolecular Pharmacology	1989	102
[3H]BIMU-1, a 5-hydroxytryptamine3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus. D W Bonhaus, Dana N. Loury, Lyn B. Jakeman, Journal of Pharmacology and Experimental Therapeutics	1993	60
Characteristics of 5‐HT<sub>3</sub> binding sites in NG108‐15, NCB‐20 neuroblastoma cells and rat cerebral cortex using [<sup>3</sup>H]‐quipazine and [<sup>3</sup>H]‐GR65630 binding Naj Sharif, Erik H.F. Wong, Dana N. Loury, British Journal of Pharmacology	1991	56
Assessment of imiloxan as a selective α<sub>2B</sub>‐adrenoceptor antagonist Anton D. Michel, Dana N. Loury, R.L. Whiting British Journal of Pharmacology Molecular PharmacologyTranslational PharmacologyMolecular PhysiologyBiochemistrySubtype Selective Ligands	1990	50
Epoxide metabolism in the liver of mice treated with clofibrate (ethyl-α-(p-chlorophenoxyisobutyrate)), a peroxisome proliferator David E. Moody, Dana N. Loury, Bruce D. Hammock Toxicology and Applied Pharmacology BiochemistryEpoxide MetabolismLiver PhysiologyPhysiologyPeroxisome Proliferator	1985	46
Effect of dietary clofibrate on epoxide hydrolase activity in tissues of mice Dana N. Loury, David E. Moody, Byung W. Kim, Biochemical Pharmacology OxysterolBiochemistryMedicineLipid PeroxidationPhysiology	1985	36
Characterization of the muscarinic receptor in isolated uterus of sham operated and ovariectomized rats Agnès Choppin, George Stepan, Dana N. Loury, British Journal of Pharmacology	1999	33
Comparison of crude and affinity purified cytosolic epoxide hydrolases from hepatic tissue of control and clofibrate-fed mice Bruce D. Hammock, Glenn D. Prestwich, Dana N. Loury, Archives of Biochemistry and Biophysics OxysterolLipid SynthesisBiochemistryMedicineLiver Physiology	1986	30
A methodology for the analysis of the preneoplastic antigen Bruce D. Hammock, Dana N. Loury, David E. Moody, Carcinogenesis HistocompatibilityImmunologyPathologyImmunophenotypingImmunotherapy	1984	28

Page 1